Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.

Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

The number of suspected cases of this neurological condition reported from the region has crossed 101. Why is it happening ...

Recurrent respiratory papillomatosis (RRP) is a disease of the upper airway presenting with exophytic wart-like lesions. These lesions are considered benign with less than a 1–5% chance of malignant ...

19) cloned into an adenovirus 5 vector to produce replication-defective Ad.CMV.IκBα (ref. 20 ). To determine if the virus was effective in inhibiting NF-κB, we infected HT1080 cells with the ...

Ltd. of Qingdao, and is currently in the process of applying for a new veterinary drug certificate. In addition, human replication-deficient adenovirus type 5 live vector CSF vaccine and chimeric CSFV ...

As discussed in the lentiviral section of SP-B deficiency, envelope, promoter, and polyadenylation signal are important considerations in designing a gene therapy vector for ABCA3 deficiency. The ...